Worldwide News

8 June, 2020 The UK based gene and cell therapy group announced that it has signed a collaboration agreement on June 8 with the Vaccines Manufacturing and Innovation Centre (VMIC) to provide the UK’s first strategic vaccine development and advanced manufacturing capability. According to Oxford Biomedica, the five-year agreement will involve the organisations working collaboratively […]

05 June, 2020 Janssen Pharmaceuticals has announced that new data from two phase 3 trials Discover-1 and Discover-2 showed that TREMFYA (guselkumab) maintained improvements in multiple clinical outcomes in adult patients with active psoriatic arthritis (PsA). The Janssen Pharmaceutical Companies of Johnson & Johnson said that new data from two Phase 3 clinical trials, Discover-1 […]

The Finnish molecular diagnostics company announced it has received CE-IVD markings for its Novodiag Covid-19 and Amplidiag Covid-19 molecular diagnostic tests for the early detection of the SARS-CoV-2 virus. These tests complement Mobidiag’s already available antibody test, Anti-SARS-CoV-2 Rapid Test, that the company is distributing from its joint venture partner in China, Autobio Diagnostics. Mobidiag […]

02 June, 2020 The developer and manufacturer of innovative laboratory tools for process optimisation, safety and scale-up, has announced the appointment of a new General Manager and Senior Vice President of North American Operations. Mert Sahin has been appointed as General Manager and Senior Vice President of H.E.L Group’s North American subsidiary, where he is […]

01 June, 2020 The clinical stage biopharmaceutical company presented the safety and efficacy results from Part I of the Matins trial in a poster at the virtual ASCO20 (American Society of Clinical Oncology) Annual Meeting. During the ASCO poster presentation, Faron Pharmaceuticals said the ongoing phase I/II Matins clinical trial is investigating the tolerability, safety […]

Gene and cell therapy group Oxford Biomedica has signed a one-year clinical and commercial supply agreement with AstraZeneca for the manufacture of a Covid-19 vaccine candidate. The agreement relates to the GMP manufacture of the adenovirus vector based Covid-19 vaccine candidate, AZD1222, which recently entered clinical trials at multiple sites in the UK. Oxford Biomedica […]

27 May, 2020 Compound sourcing specialist MolPort has announced the successful completion of 100 projects in partnership with BioAscent, one of the leading providers of integrated drug discovery services based in the UK. Through their collaborative efforts, MolPort and BioAscent said they have significantly enhanced customer service by providing compounds in consistent formats and times, […]

26 May, 2020 GlaxoSmithKline (GSK) and Samsung Biologics announced they have entered into a partnership to provide GSK with additional capacity to manufacture and supply its innovative biopharmaceutical therapies. Under the terms of the agreement, Samsung Biologics is to provide GSK with additional capacity for large-scale biopharmaceutical product manufacturing, which will be flexible depending on […]

New antibody internalization advanced screening method provides greater speed & insight 26 May 2020 Sponsored by Sartorius Researchers abilities to improve the breadth of therapeutic antibodies have been aided by innovative technologies for antibody discovery, for instance, through humanization of mouse antibodies and phage display. However, advanced antibody design techniques create the need for new […]

22 May, 2020 The International Society for Pharmaceutical Engineering (ISPE) has announced the appointment of a new CEO and President. Effective June 1, Thomas B. Hartman has been appointed as ISPE’s CEO and President. With a solid track record in the pharmaceutical industry, rising to the role of Vice President of GMP Operations, Biopharm CMC, […]